Tarbox Family Office’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $509K | Sell |
553
-344
| -38% | -$349K | 0.08% | 64 |
|
|
2025
Q4 | $964K | Sell |
897
-66
| -7% | -$63.1K | 0.16% | 44 |
|
|
2025
Q3 | $735K | Sell |
963
-2
| -0.2% | -$1.49K | 0.11% | 57 |
|
|
2025
Q2 | $752K | Buy |
965
+1
| +0.1% | +$777 | 0.11% | 51 |
|
|
2025
Q1 | $796K | Hold |
964
| – | – | 0.13% | 48 |
|
|
2024
Q4 | $744K | Sell |
964
-4
| -0.4% | -$3.31K | 0.12% | 52 |
|
|
2024
Q3 | $858K | Sell |
968
-3
| -0.3% | -$2.7K | 0.14% | 42 |
|
|
2024
Q2 | $879K | Sell |
971
-5
| -0.5% | -$4K | 0.16% | 40 |
|
|
2024
Q1 | $759K | Sell |
976
-4
| -0.4% | -$2.85K | 0.13% | 45 |
|
|
2023
Q4 | $571K | Buy |
980
+12
| +1% | +$7K | 0.11% | 49 |
|
|
2023
Q3 | $520K | Sell |
968
-16
| -2% | -$8.24K | 0.11% | 54 |
|
|
2023
Q2 | $462K | Sell |
984
-5
| -0.5% | -$2.1K | 0.09% | 64 |
|
|
2023
Q1 | $340K | Sell |
989
-1
| -0.1% | -$337 | 0.07% | 76 |
|
|
2022
Q4 | $362K | Sell |
990
-9
| -0.9% | -$3.19K | 0.08% | 71 |
|
|
2022
Q3 | $324K | Hold |
999
| – | – | 0.08% | 70 |
|
|
2022
Q2 | $324K | Sell |
999
-19
| -2% | -$5.7K | 0.07% | 85 |
|
|
2022
Q1 | $292K | Sell |
1,018
-138
| -12% | -$35.5K | 0.06% | 76 |
|
|
2021
Q4 | $319K | Buy |
1,156
+8
| +0.7% | +$2.03K | 0.05% | 100 |
|
|
2021
Q3 | $265K | Sell |
1,148
-7
| -0.6% | -$1.73K | 0.05% | 119 |
|
|
2021
Q2 | $265K | Hold |
1,155
| – | – | 0.05% | 123 |
|
|
2021
Q1 | $216K | Hold |
1,155
| – | – | 0.04% | 117 |
|
|
2020
Q4 | $195K | Sell |
1,155
-13
| -1% | -$1.94K | 0.04% | 121 |
|
|
2020
Q3 | $173K | Buy |
1,168
+1
| +0.1% | +$155 | 0.04% | 125 |
|
|
2020
Q2 | $192K | Buy |
1,167
+37
| +3% | +$5.68K | 0.05% | 115 |
|
|
2020
Q1 | $157K | Buy |
1,130
+75
| +7% | +$10.3K | 0.05% | 117 |
|
|
2019
Q4 | $139K | Sell |
1,055
-209
| -17% | -$24.2K | 0.04% | 125 |
|
|
2019
Q3 | $141K | Hold |
1,264
| – | – | 0.04% | 105 |
|
|
2019
Q2 | $140K | Buy |
1,264
+66
| +6% | +$7.77K | 0.04% | 105 |
|
|
2019
Q1 | $155K | Hold |
1,198
| – | – | 0.06% | 96 |
|
|
2018
Q4 | $139K | Sell |
1,198
-463
| -28% | -$51.7K | 0.06% | 96 |
|
|
2018
Q3 | $178K | Hold |
1,661
| – | – | 0.06% | 96 |
|
|
2018
Q2 | $142K | Buy |
1,661
+74
| +5% | +$6.08K | 0.05% | 102 |
|
|
2018
Q1 | $123K | Sell |
1,587
-3
| -0.2% | -$242 | 0.05% | 109 |
|
|
2017
Q4 | $134K | Hold |
1,590
| – | – | 0.05% | 106 |
|
|
2017
Q3 | $136K | Buy |
1,590
+40
| +3% | +$3.28K | 0.06% | 97 |
|
|
2017
Q2 | $128K | Hold |
1,550
| – | – | 0.06% | 96 |
|
|
2017
Q1 | $130K | Sell |
1,550
-3
| -0.2% | -$240 | 0.07% | 80 |
|
|
2016
Q4 | $114K | Buy |
1,553
+14
| +0.9% | +$1.04K | 0.07% | 74 |
|
|
2016
Q3 | $124K | Buy |
1,539
+11
| +0.7% | +$880 | 0.08% | 70 |
|
|
2016
Q2 | $120K | Hold |
1,528
| – | – | 0.09% | 68 |
|
|
2016
Q1 | $110K | Sell |
1,528
-44
| -3% | -$3.33K | 0.08% | 74 |
|
|
2015
Q4 | $132K | Sell |
1,572
-10
| -0.6% | -$830 | 0.11% | 58 |
|
|
2015
Q3 | $132K | Buy |
1,582
+1,175
| +289% | +$99.2K | 0.12% | 60 |
|
|
2015
Q2 | $34K | Sell |
407
-20
| -5% | -$1.52K | 0.03% | 118 |
|
|
2015
Q1 | $31K | Hold |
427
| – | – | 0.03% | 126 |
|
|
2014
Q4 | $29K | Sell |
427
-990
| -70% | -$66.8K | 0.03% | 131 |
|
|
2014
Q3 | $92K | Buy |
1,417
+1,025
| +261% | +$64.9K | 0.08% | 79 |
|
|
2014
Q2 | $24K | Sell |
392
-2,243
| -85% | -$134K | 0.02% | 142 |
|
|
2014
Q1 | $155K | Buy |
2,635
+14
| +0.5% | +$781 | 0.14% | 63 |
|
|
2013
Q4 | $134K | Buy |
+2,621
| New | +$131K | 0.11% | 82 |
|
Other funds holding LLY
VCM
VPM
Tarbox Family Office's LLY Position: Q1 2026 in Review
Tarbox Family Office reduced its Eli Lilly (LLY) stake by 38% in Q1 2026, selling an estimated $349K and leaving 553 shares worth $509K. The position accounts for 0.08% of the portfolio, ranked #64.
Tarbox Family Office first reported a position in LLY in Q4 2013 and has held it in 50 quarters since. The position peaked at $964K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Tarbox Family Office held 553 shares of Eli Lilly worth $509K as of Q1 2026.
- Tarbox Family Office sold 344 Eli Lilly shares in Q1 2026, an estimated $349K.
- Eli Lilly made up 0.08% of Tarbox Family Office's portfolio in Q1 2026, its #64 holding.
- Tarbox Family Office first reported a position in Eli Lilly in Q4 2013 and has held it in 50 quarters since.
- Tarbox Family Office's Eli Lilly position peaked at $964K in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Tarbox Family Office's 13F filing for Q1 2026, filed 24 Apr 2026.